z-logo
Premium
Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia
Author(s) -
Hallner Alexander,
Aurelius Johan,
Thorén Fredrik Bergh,
Sander Frida Ewald,
Brune Mats,
Hellstrand Kristoffer,
Martner Anna
Publication year - 2015
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.12454
Subject(s) - medicine , myeloid leukemia , immunotherapy , transplantation , lymphocyte , immunology , leukemia , clinical trial , hematopoietic stem cell transplantation , histamine , oncology , gastroenterology , immune system

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here